相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Novel IL-21 signaling pathway up-regulates c-Myc and induces apoptosis of diffuse large B-cell lymphomas
Kristopher A. Sarosiek et al.
BLOOD (2010)
Dual inhibition of PI3K and mTOR inhibits autocrine and paracrine proliferative loops in PI3K/Akt/mTOR-addicted lymphomas
Aadra P. Bhatt et al.
BLOOD (2010)
Interleukin-4 distinctively modifies responses of germinal centre-like and activated B-cell-like diffuse large B-cell lymphomas to immuno-chemotherapy
Kristopher A. Sarosiek et al.
BRITISH JOURNAL OF HAEMATOLOGY (2009)
Bortezomib Overcomes Tumor Necrosis Factor-related Apoptosis-inducing Ligand Resistance in Hepatocellular Carcinoma Cells in Part through the Inhibition of the Phosphatidylinositol 3-Kinase/Akt Pathway
Kuen-Feng Chen et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2009)
Induction of heme oxygenase-1 by cobalt protoporphyrin enhances the antitumour effect of bortezomib in adult T-cell leukaemia cells
R. S. Hamamura et al.
BRITISH JOURNAL OF CANCER (2007)
Deregulation of c-Myc in primary effusion lymphoma by Kaposi's sarcoma herpesvirus latency-associated nuclear antigen
D. Bubman et al.
ONCOGENE (2007)
In vivo-restricted and reversible malignancy induced by human herpesvirus-8 KSHV: A cell and animal model of virally induced Kaposi's sarcoma
Agata D'Agostino Mutlu et al.
CANCER CELL (2007)
Global mapping of c-Myc binding sites and target gene networks in human B cells
Karen I. Zeller et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2006)
Proteasome inhibitors induce a terminal unfolded protein response in multiple myeloma cells
Esther A. Obeng et al.
BLOOD (2006)
Oncogenic pathway signatures in human cancers as a guide to targeted therapies
AH Bild et al.
NATURE (2006)
The KSHV oncoprotein vFLIP contains a TRAF-interacting motif and requires TRAF2 and TRAF3 for signalling
I Guasparri et al.
EMBO REPORTS (2006)
Prognostic factors and outcome of human herpesvirus 8-associated primary effusion lymphoma in patients with AIDS
E Boulanger et al.
JOURNAL OF CLINICAL ONCOLOGY (2005)
Azidothymidine inhibits NF-κB and induces Epstein-Barr virus gene expression in Burkitt lymphoma
M Kurokawa et al.
BLOOD (2005)
Bortezomib or high-dose dexamethasone for relapsed multiple myeloma
PG Richardson et al.
NEW ENGLAND JOURNAL OF MEDICINE (2005)
The targeting of primary effusion lymphoma cells for apoptosi by inducing lytic replication of human herpesvirus 8 while blocking virus production
CM Klass et al.
BLOOD (2005)
Inhibition of HHV-8/KSHV infected primary effusion lymphomas in NOD/SCID mice by azidothymidine and interferon-α
W Wu et al.
LEUKEMIA RESEARCH (2005)
The ER chaperone and signaling regulator GRP78/BiP as a monitor of endoplasmic reticulum stress
AS Lee
METHODS (2005)
Kaposi's sarcoma-associated herpesvirus/human herpesvirus type 8-positive solid lymphomas - A tissue-based variant of primary effusion lymphoma
A Carbone et al.
JOURNAL OF MOLECULAR DIAGNOSTICS (2005)
Phase II clinical experience with the novel proteasome inhibitor bortezomib in patients with indolent non-Hodgkin's lymphoma and mantle cell lymphoma
OA O'Connor et al.
JOURNAL OF CLINICAL ONCOLOGY (2005)
KSHV vFLIP is essential for the survival of infected lymphoma cells
I Guasparri et al.
JOURNAL OF EXPERIMENTAL MEDICINE (2004)
The KSHV G protein-coupled receptor signals via multiple pathways to induce transcription factor activation in primary effusion lymphoma cells
ML Cannon et al.
ONCOGENE (2004)
Antitumor effects of bortezomib (PS-341) on primary effusion lymphomas
J An et al.
LEUKEMIA (2004)
The tumor microenvironment controls primary effusion lymphoma growth in vivo
MR Staudt et al.
CANCER RESEARCH (2004)
Myc pathways provoking cell suicide and cancer
JA Nilsson et al.
ONCOGENE (2003)
Kaposi's sarcoma-associated herpesvirus-infected primary effusion lymphoma has a gene expression profile
RG Jenner et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2003)
Clinical features and outcome of primary effusion lymphoma in HIV-infected patients: A single-institution study
C Simonelli et al.
JOURNAL OF CLINICAL ONCOLOGY (2003)
Induction of a TRAIL mediated suicide program by interferon alpha in primary effusion lymphoma
NL Toomey et al.
ONCOGENE (2001)
Kaposi's sarcoma-associated herpesvirus latency-associated nuclear antigen 1 mediates episome persistence through cis-acting terminal repeat (TR) sequence and specifically binds TR DNA
ME Ballestas et al.
JOURNAL OF VIROLOGY (2001)
Regulated translation initiation controls stress-induced gene expression in mammalian cells
HP Harding et al.
MOLECULAR CELL (2000)
Monoclonality or oligoclonality of human herpesvirus 8 terminal repeat sequences in Kaposi's sarcoma and other diseases
JG Judde et al.
JNCI-JOURNAL OF THE NATIONAL CANCER INSTITUTE (2000)
Differential viral protein expression in Kaposi's sarcoma-associated herpesvirus-infected diseases - Kaposi's sarcoma, primary effusion lymphoma, and multicentric Castleman's disease
C Parravicini et al.
AMERICAN JOURNAL OF PATHOLOGY (2000)
分享论文
